United States · Medical devices startup

BridgePoint Medical, Inc.

BridgePoint Medical, Inc.

Funding reportedLast round: Series C

Medical devicesMinneapolis, United States

About BridgePoint Medical, Inc.

BridgePoint Medical, Inc.

was a medical device company based in Minneapolis, Minnesota, founded in 2007. The company focused on developing catheter-based technologies specifically for treating coronary chronic total occlusions (CTOs) in interventional cardiology. BridgePoint specialized in proprietary systems designed to address CTOs, which affect a significant portion of angiography patients and can lead to invasive bypass surgery. The company's key products included the CrossBossTM CTO Catheter, which helps navigate diseased coronary arteries, and the StingrayTM CTO Re-Entry System, which restores blood flow after crossing. Together, these formed the BridgePoint Medical CTO System, the only FDA-cleared and CE Mark-approved system in the U.S. for coronary CTOs at the time. In September 2012, BridgePoint was acquired by Boston Scientific Corporation, integrating its technologies into a larger portfolio.

What company datasets say BridgePoint Medical, Inc. raised

Funding, as reported

Reported in all$25Min dollars
Last roundSeries C
Last round size$9.1M
Last round dateMar 2011

Founders and team

From the SEC filings it signed: 4 on the team.

  • Chad KuglerExecutive Officer, Directori
  • Craig SchlawinExecutive Officeri
  • John SchultzExecutive Officeri
  • Matthew OlsonExecutive Officeri

On the board, as filediAndrew FirlikBrian CheeJohn NehraMichael Berman

The company, in detail

What they build

Known for

health caremedical equipment manufacturinghospital & health carehealthmedical deviceshealthcarewellness & fitness

Sector
Medical devices
Region
Minnesota
Part of
Boston Scientific
Revenue
$10M a year, as listed

Medical devices in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put BridgePoint Medical, Inc. in front of investors. Or tell us what we have wrong.